自拟养气健肺汤联合噻托溴铵治疗肺气虚证 稳定期 COPD 的临床疗效
CSTR:
作者:
作者单位:

作者简介:

林文娟,女,主治医师,主要研究方向是老年病。

通讯作者:

中图分类号:

R 563

基金项目:

福建省卫健委青年科研项目(2020QNA065)


Clinical Efficacy of Self-designed Yangqi Jianfei Decoction Combined with Tiotropium Bromide in the Treatment of Stable COPD with lung qi deficiency
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘 要目的:探讨自拟养气健肺汤联合噻托溴铵治疗肺气虚证稳定期慢性阻塞性肺疾病(COPD)的疗效及安 全性。 方法:采用随机对照研究方法将 2021 年 1 月至 2022 年 1 月在福建中医药大学附属第二人民医院诊治的 64 例 稳定期 COPD 患者分为对照组(噻托溴铵治疗)及观察组(自拟养气健肺汤联合噻托溴铵治疗),比较两组患者治 疗前及治疗后肺功能、中医证候积分、6 min 步行试验(6MWT)及 COPD 评分(CAT)的差异。 结果:两组患者治 疗后第 1 秒用力呼气容积(FEV1)、FEV1%、FEV1/ 用力肺活量(FVC)均较治疗前有不同程度提高,且观察组患 者治疗后 FEV1、FEV1%、FEV1/FVC 均较对照组高,差异具有统计学意义(P < 0.05)。两组患者治疗后中医证候 积分均较治疗前有不同程度下降,且观察组患者治疗后中医证候积分较对照组低,差异具有统计学意义(P < 0.05)。 两组患者治疗后 6MWT 均较治疗前有不同程度提升,CAT 评分较治疗前有不同程度降低,且观察组患者治疗后 6MWT 较对照组远,CAT 评分较对照组低,差异具有统计学意义(P < 0.05)。两组患者治疗中均未见明显不良反应。 结论:自拟养气健肺汤联合噻托溴铵治疗可显著改善肺气虚证稳定期 COPD 患者心肺功能,减轻临床症状,提高生 活质量,并具有高效安全等优点。

    Abstract:

    AbstractObjective To investigate the efficacy and safety of self-designed Yangqi Jianfei decoction combined with Tiotropium bromide in the treatment of stable chronic obstructive pulmonary diseases (COPD) with lung qi deficiency. Methods 64 patients with stable COPD treated in the Second People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine from January 2021 to January 2022 were divided into a control group (tiotropium bromide treatment) and an observation group (self-designed Yangqi Jianfei decoction combined with tiotropium bromide treatment). The differences of lung function, traditional Chinese medical syndrome score, 6 minutes walk test (6MWT) and COPD assessment test (CAT) were compared between the two groups before and after treatment. Results Forced expiratory volume in first second (FEV1), FEV1% and FEV1/ forced vital capacity (FVC) after treatment in the two groups were improved in different degrees compared with before treatment, and FEV1, FEV1% and FEV1/FVC in the observation group were higher than those in the control group after treatment, the differences were statistically significant (P < 0.05). The TCM syndrome scores of the two groups were decreased to different degrees after treatment, and the TCM syndrome score of the observation group was lower than that of the control group after treatment, the differences were statistically significant (P < 0.05). Compared with before treatment, 6MWT in the two groups was improved to different degrees, and CAT score decreased to different degrees. Moreover, 6MWT in the observation group was further than that in the control group after treatment, and CAT score was lower than that in the control group, with statistical significance (P < 0.05). No obvious adverse reaction was observed in the two groups. Conclusion Self-designed Yangqi Jianfei decoction combined with Tiotropium bromide can significantly improve the cardiopulmonary function, reduce clinical symptoms, improve quality of life in stable COPD with lung qi deficiency patients, and has the advantages of high efficiency and safety.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-01-25
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-07-10
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭